MedPage Today on MSN
Non-Ablative Treatment for BPH/LUTS Achieves Rapid, Sustained Improvements
Results with Optilume consistent in clinical trials and real world, regardless of prostate ...
Navigator models, particularly cross-specialty nurse navigation, reduce stress, expedite diagnosis-to-treatment transitions, ...
(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...
A UAG medical school degree can take a prospective physician anywhere they choose. UAG’s alumni are a testament to the ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated ...
A new clinical trial led by the Alliance for Clinical Trials in Oncology will investigate if a combination of drug therapies ...
A powerful new real-world data platform could transform how scientists predict and understand Alzheimer's disease and ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated ...
The MarketWatch News Department was not involved in the creation of this content. BRONX, N.Y. , March 18, 2026 /PRNewswire/ -- Michelle Ng Gong, M.D., M.S., has been appointed chair of the Montefiore ...
In the management of Crohn’s disease, a key objective — preserving the bowel by reducing the need for multiple resections — ...
At a time when faith in public institutions is wavering, a new book challenges one of healthcare's most entrenched ...
Alcon agreed to buy LENSAR for $14.00/share cash, integrating ALLY, Streamline, and the legacy laser system to expand FLACS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results